644 results on '"Lämmle B"'
Search Results
102. Binding of α-thrombin to fibrin depends on the quality of the fibrin network
103. Hereditary thrombotic thrombo-cytopenic purpura and the hereditary TTP registry.
104. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011.
105. Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers.
106. Functional Characterization of a Variant Prekallikrein (PK Zürich)
107. 167. Nachuntersuchungen bei 100 Patienten mit operativ gesichertem primarem Hyperparathyreoidismus
108. Determination of thrombin-antithrombin-III-complex is not a suitable screening test for detecting deficiency of protein C or protein S
109. Rebuttal to the Letter of F. Rodeghiero et al. -Thrombosis in Subjects with Homozygous and Heterozygous Factor XII Deficiency
110. Major Coagulation Disorders when using Aprotinin - Observations on a Case
111. Rebuttal to the Letter to the Editor by W. P. M. Houdijk
112. Decreased Free Protein S Levels in Polycythemia Vera
113. Late onset and pregnancy-induced congenital thrombotic thrombocytopenic purpura
114. Bilateral periorbital ecchymoses
115. Tryptase from human mast cells does not activate purified human Hageman Factor.
116. Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosis.
117. The von Willebrand Factor-Cleaving Protease (ADAMTS-13) and the Diagnosis of Thrombotic Thrombocytopenic Purpura (TTP)
118. Genetic Predisposition to Bleeding during Oral Anticoagulant Therapy: Evidence for Common Founder Mutations (FIXVal-10 and FIXThr-10) and an Independent CpG Hotspot Mutation (FIXThr-10)
119. Factor XII, Plasma Prekallikrein, α2-Macroglobulin and C1-Inhibitor Levels in Renal Allograft Recipients During Immunosuppression with Cyclosporin A – Sequential Measurements over Four Months in 17 Patients
120. Is Plasminogen Deficiency a Thrombotic Risk Factor ? – A Study on 23 Thrombophilic Patients and their Family Members
121. Protein S und venöse Thrombophilie
122. Therapie der akuten tiefen Beinvenenthrombose mit niedermolekularen Heparinen
123. Thrombotic Risk of Women with Hereditary Antithrombin III-, Protein C- and Protein S-Deficiency Taking Oral Contraceptive Medication
124. Heparin Cofactor II: Purification and Antibody Production
125. Fifteen Coagulation and Fibrinolysis Parameters in Diabetes Mellitus and in Patients with Vasculopathy
126. Platelet Aggregation, β-Thromboglobulin and Platelet Factor 4 in Diabetes Mellitus and in Patients with Vasculopathy
127. Plasmin Inhibitors and Fibrinogen Breakdown During the Initial Phase of Thrombolytic Treatment - The Problem of the α2-Antiplasmin Determination
128. Different Assessment of Plasmin with Different Substrates
129. Monitoring of Oral Anticoagulation by an Amidolytic Factor X Assay
130. 1,25 (OH)2 Vitamin D3 in Osteoporosis - A Pilot Study
131. Autoactivation of human plasma prekallikrein.
132. Low molecular weight heparin-induced thrombocytopenia and skin necrosis distant from injection sites.
133. SEVERE OSTEOPOROSIS DUE TO SYSTEMIC MAST CELL DISEASE: SUCCESSFUL TREATMENT WITH INTERFERON ALPHA-2B.
134. Acquired deficiency of von Willebrand factor-cleaving protease in a patient suffering from acute systemic lupus erythematosus
135. Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura--new insights into underlying biochemical mechanisms.
136. Schistocytic anaemia, severe thrombocytopenia, and renal dysfunction: thrombotic microangiopathy due to severe acquired ADAMTS-13 deficiency. Case 2
137. Acquired von Willebrand syndrome in a myeloproliferative disorder. Case 6
138. Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory
139. Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura
140. Acute pancreatitis and thrombotic thrombocytopenic purpura
141. SEVERE OSTEOPOROSIS DUE TO SYSTEMIC MAST CELL DISEASE: SUCCESSFUL TREATMENT WITH INTERFERON ALPHA-2B
142. Acquired deficiency of von Willebrand factor‐cleaving protease in a patient suffering from acute systemic lupus erythematosus
143. Prekallikrein Activator - Reply
144. Protein S und venöse Thrombophilie
145. Comments on ‘quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody’ by Reddigari and Kaplan
146. The Contact Phase of Blood Coagulation in Diabetes Mellitus and in Patients with Vasculopathy
147. How high is the true fibrinogen content of fibrinogen standards?
148. In Vitro Effects of the Acylated StreptokinasePlasminogen Activator Complex BRL 33 575 Incubated with Normal Human Plasma
149. FACTOR XII, PLASMA PREKALLIKREIN ,α2-MACROGLOBULIN AND C1-INHIBITOR LEVELS IN RENAL ALLOGRAFT RECIPIENTS DURING IMMUNOSUPPRESSION WITH CYCLOSPORIN A
150. Cold Promoted Activation and Factor XII, Prekallikrein and C1-Inhibitor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.